Unicycive Therapeutics, Inc. 10-Q

ITEM 5. OTHER INFORMATION Not applicable . ITEM 6. EXHIBITS Exhibit No. Description 31.1 Certification of Principal Executive Officer required under Rule 13a-14(a)/15d-14(a) under the Exchange Act. 31.2 Certification of Principal Financial Officer required under Rule 13a-14(a)/15d-14(a) under the Exchange Act. 32.1 Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 32.2 Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 41 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized on the 13th day of May, 2024. Signature Title Date /s/ Shalabh Gupta Chief Executive Officer, President and Chairman May 13, 2024 Shalabh Gupta (Principal Executive Officer) /s/ John Townsend Chief Financial Officer May 13, 2024 John Townsend (Principal Financial and Accounting Officer) 42